🇺🇸 Warfarin-Natrium in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 8

Most-reported reactions

1. Back Pain — 1 report (12.5%)
2. Chronic Obstructive Pulmonary Disease — 1 report (12.5%)
3. Dry Gangrene — 1 report (12.5%)
4. Gastric Disorder — 1 report (12.5%)
5. Hepatic Enzyme Increased — 1 report (12.5%)
6. Herpes Zoster — 1 report (12.5%)
7. Peripheral Artery Thrombosis — 1 report (12.5%)
8. Syncope — 1 report (12.5%)

Source database →

Frequently asked questions

Is Warfarin-Natrium approved in United States?

Warfarin-Natrium does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Warfarin-Natrium in United States?

University Hospital, Bonn is the originator. The local marketing authorisation holder may differ — check the official source linked above.